SESCW — what changed in the latest 10-Q
A section-by-section comparison of SESCW's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-08-11 vs the prior 10-Q · 2026-04-24
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +23 | −17 | ~11 | 15 |
| Market risk (Item 3) | Text added/removed | 0 | 0 | ~1 | 0 |
| Controls & procedures | Text added/removed | +1 | 0 | ~1 | 1 |
| Legal proceedings | Text added/removed | +1 | −1 | 0 | 0 |
| Risk factors | No material changes reported (points to the 10-K) | — | — | — | — |
| Other information | Text added/removed | +3 | −1 | 0 | 0 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-08-11
that is sufficient to achieve profitability will depend largely on the successful development of our products and services. Accordingly, the drivers of our future financial results, as well as the components of such results, may not be comparable to our historical results of operations
Revenue from customers for the three and six months ended June 30, 2026 was $5.1 million and $11.8 million, respectively. Revenue increased by $1.5 million and $2.5 million, respectively, compared to the three and six months ended June 30, 2025, which had revenue of $3.5 million and $9.3 million, re…
Services revenue decreased $3.5 million and $9.0 million for the three and six months ended June 30, 2026 compared to the three and six months ended June 30, 2025. Product revenue increased $5.1 million and $11.5 million for the three and six months ended June 30, 2026 compared to the three and six …
Costs of revenue for the three and six months ended June 30, 2026 were $3.9 million and $9.4 million, respectively. Cost of revenue increased by $3.0 million and $7.3 million, or 323% and 336%, respectively, compared to the three and six months ended June 30, 2025, which had costs of revenue of $0.9…
testing, payments made to consultants, and patent related legal costs. Furthermore, they encompass depreciation, allocated facilities expenses, and information technology costs, including costs incurred for renting graphic processing units (“GPUs”) to train AI models.
Text removed vs the prior filing · source: 10-Q · 2026-04-24
Revenue from customers for the three months ended March 31, 2026 increased $0.9 million to $6.7 million compared to $5.8 million for the three months ended March 31, 2025.
Service revenues decreased $5.5 million, or nearly 95%, to $0.3 million for the three months ended March 31, 2026 compared to $5.8 million for the three months ended March 31, 2025. This decrease was primarily attributable to completion of the service revenue projects with OEMs and other manufacture…
Costs of revenue for the three months ended March 31, 2026 increased $4.3 million, or nearly 78%, to $5.5 million compared to $1.2 million for the three months ended March 31, 2025. Costs related to service revenues decreased $1.1 million, or 92%, to $0.1 million for the three months ended March 31,…
Research and development expenses for the three months ended March 31, 2026 decreased $9.5 million, or 46.2%, to $11.0 million, compared with $20.5 million for the three months ended March 31, 2025. This decrease primarily resulted from a $5.4 million decrease in automotive OEM JDA related lab equip…
General and administrative expenses for the three months ended March 31, 2026 increased $0.7 million, or 10.0%, to $8.1 million, compared with $7.3 million for the three months ended March 31, 2025. This increase primarily resulted from a $0.8 million increase in salaries, and benefits expense due t…
Controls & procedures
Text added vs the prior filing · source: 10-Q · 2026-08-11
There have been no changes in our internal control over financial reporting during the most recent fiscal quarter that materially affected, or which are reasonably likely to materially affect, our internal control over financial reporting.
Legal proceedings
Text added vs the prior filing · source: 10-Q · 2026-08-11
Information regarding legal proceedings is available in Note 10 to the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q.
Text removed vs the prior filing · source: 10-Q · 2026-04-24
From time to time, we may be subject to claims arising in the ordinary course of business or become involved in litigation or other legal proceedings. We are not currently a party to any litigation or legal proceedings that, in the opinion of our management, are likely to have a material adverse eff…
Other information
Text added vs the prior filing · source: 10-Q · 2026-08-11
(a)Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On August 6, 2026, the Company determined that effective August 15, 2026, Kang Xu, our Chief Technology Officer, will receive a reduced base salary of $110,000, as he begins splitting time between the Company and The Ohio State University, where he has been named an Ohio Eminent Scholar and Howard D…
(c)During the fiscal quarter ended June 30, 2026, none of our directors or Section 16 officers adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K, except as follows: on May 18, 2026, each of our…
Text removed vs the prior filing · source: 10-Q · 2026-04-24
On March 9, 2026, Hong Gan (our Chief Science Officer) adopted a trading plan intended to satisfy the conditions under Rule 10b5-1(c) of the Exchange Act. Dr. Gan’s plan is for the potential exercise of up to 929,832 fully stock options expiring on February 10, 2031, and the sale of the shares of Cl…
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice